Steve Krognes
Director at Denali Therapeutics; Director at Guardant Health. Based in Palo Alto, California.
- Rank
- 6090th of 14,644
- Companies held
- 2
- Largest holding
- DNLI, 92.8% of total
- Latest SEC filing
- Sep 16, 2026
What the $16.1M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Denali Therapeutics DNLI Common Stock | Through Steve Edward Krognes Revocable Trust | 781,797 | $18.20 | $14.2M | 88.5% | Form 4, Jun 3, 2026 |
| Guardant Health GH Common Stock | Directly | 7,906 | $145.59 | $1.2M | 7.2% | Form 4, Sep 16, 2026 |
| Denali Therapeutics DNLI Common Stock | Directly | 38,202 | $18.20 | $695K | 4.3% | Form 4, Jun 3, 2026 |
Share counts are the amounts Steve Krognes reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 6087 | Marlene Debel EVP & Chief Risk Officer, MetLife. New York, NY | $16.1M |
| 6088 | Calvin Butler Jr President & CEO, Exelon. St. Louis, MO | $16.1M |
| 6089 | Robert F. Cummings Jr. Director, Corning. Corning, NY | $16.1M |
| 6090 | Steve Krognes Director, Denali Therapeutics. Palo Alto, CA | $16.1M |
| 6091 | Ronald L. Olson Director, Berkshire Hathaway. San Francisco, CA | $16.1M |
| 6092 | Nicholas Earl Director, Powerlaw. San Francisco, CA | $16.1M |
| 6093 | Jose E. Almeida Chairman, CEO, President, Baxter International. Charlotte, NC | $16.1M |
Other Denali Therapeutics insiders
All DNLI insiders- Ryan J. Watts$44.0MPresident and CEO. #2789 overall
- Marc Tessier-Lavigne$35.8MDirector. #3115 overall
- Alexander O. Schuth$14.6MCOFO and Secretary. #6577 overall
- Carole Ho$7.7MChief Medical Officer. #9813 overall
- Jay T. Flatley$6.5MDirector. #9869 overall
- Vicki L. Sato$2.0MDirector. #7845 overall
Questions
How much stock does Steve Krognes own?
Steve Krognes holds $16,075,016 in listed stock based on SEC filings and current prices, mostly Denali Therapeutics (DNLI). That ranks 6090th on the Stock Rich List.
Is this Steve Krognes's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Steve Krognes last buy or sell stock?
The most recent open-market trade on file is a sale of 1,103 GH shares on Sep 16, 2026 at $174.46.